The Management of EGFR Inhibitor Adverse Events: A Case Series and Treatment Paradigm

    January 2012 in “ International Journal of Dermatology ”
    Amelia M. Wnorowski, Aieska de Souza, Abraham Chachoua, David Cohen
    Studysummary This study reported that the most common skin side effect of epidermal growth factor receptor inhibitors was a papulopustular rash, treatable with symptom-targeted therapies, while drug suspension was rarely needed.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Persistent Hair Growth During Treatment With the EGFR Inhibitor Erlotinib Dermatology Online Journal · 2009
    2. Follicular and Epidermal Alterations in Patients Treated with ZD1839 (Iressa), an Inhibitor of the Epidermal Growth Factor Receptor British journal of dermatology/British journal of dermatology, Supplement · 2002